Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Liver transplantation.

Kimberly A Brown1

  • 1Division of Gastroenterology, Henry Ford Hospital, Detroit, MI 48202, USA. kbrown1@hfhs.org

Current Opinion in Gastroenterology
|April 9, 2005
PubMed
Summary
This summary is machine-generated.

Liver transplantation outcomes are improving, but the Model for End-Stage Renal Disease (MELD) score

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Antiviral treatment and statin use and risk of decompensated cirrhosis in patients with hepatitis C: a time-dependent analysis of a retrospective cohort study.

BMJ open gastroenterology·2026
Same author

Challenges in the Treatment of Hepatorenal Syndrome-Acute Kidney Injury: A US Chart Review of Treatment Patterns and Survival Outcomes.

JGH open : an open access journal of gastroenterology and hepatology·2025
Same author

Screening and management of portal hypertension and varices in cirrhosis: Expert perspectives.

Hepatology communications·2025
Same author

Modeling HCV elimination recovery following the COVID-19 pandemic in the United States: Pathways to regain progress.

Journal of infection and public health·2022
Same author

Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes.

The American journal of medicine·2021
Same author

From Heresy to Standard of Care: A Virologic Journey.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2021
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Area of Science:

  • Hepatology and Transplant Surgery
  • Organ Allocation and Utilization
  • Post-transplant Complications

Background:

  • Liver transplantation is a critical treatment for end-stage liver disease.
  • Organ scarcity necessitates refined criteria for allocation and utilization.
  • Evolving trends impact patient selection and post-transplant care.

Purpose of the Study:

  • To review new trends and ideas in liver transplantation.
  • To evaluate the effectiveness of the Model for End-Stage Renal Disease (MELD) scoring system.
  • To discuss factors influencing outcomes in hepatitis C virus (HCV) infected patients.

Main Methods:

  • Review of current literature on liver transplantation trends.
  • Analysis of the MELD scoring system's predictive accuracy.

Related Experiment Videos

  • Examination of variables affecting outcomes in HCV-positive recipients.

    • Main Results:

    • MELD score accurately predicts pre-transplant mortality but may be less accurate post-transplant.
    • MELD benefits hepatocellular carcinoma patients, improving survival.
    • Donor age impacts outcomes in HCV patients; LDLT controversy persists.
    • Post-transplant HCV treatment can improve virologic response and histology.
    • Renal dysfunction post-transplant requires preventative strategies.

    Conclusions:

    • The MELD system has limitations in organ allocation equity.
    • Optimizing outcomes for HCV patients requires careful donor selection and post-transplant management.
    • Addressing post-transplant complications like renal dysfunction is crucial for improving long-term survival.